APA

Goy A., Bernstein S. H., Kahl B. S., Djulbegovic B., Robertson M. J., de Vos S., Epner E., Krishnan A., Leonard J. P., Lonial S., Nasta S., O'Connor O. A., Shi H., Boral A. L. & Fisher R. I. (20090519). Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Goy A, Bernstein S H, Kahl B S, Djulbegovic B, Robertson M J, de Vos S, Epner E, Krishnan A, Leonard J P, Lonial S, Nasta S, O'Connor O A, Shi H, Boral A L and Fisher R I. 20090519. Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Goy A., Bernstein S. H., Kahl B. S., Djulbegovic B., Robertson M. J., de Vos S., Epner E., Krishnan A., Leonard J. P., Lonial S., Nasta S., O'Connor O. A., Shi H., Boral A. L. and Fisher R. I. (20090519). Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Goy A, Bernstein S H, Kahl B S, Djulbegovic B, Robertson M J, de Vos S, Epner E, Krishnan A, Leonard J P, Lonial S, Nasta S, O'Connor O A, Shi H, Boral A L and Fisher R I. Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study. : Annals of oncology : official journal of the European Society for Medical Oncology. 20090519.